162 results
8-K
LXRX
Lexicon Pharmaceuticals Inc
29 Apr 24
Departure of Directors or Certain Officers
9:00am
of Certain Officers
(b) On April 24, 2024, Lonnel Coats notified us of his retirement as our chief executive officer (in which capacity, Mr. Coats
8-K
EX-10.1
3u8opfqkz 8bskamb
11 Mar 24
Lexicon Pharmaceuticals Reports Fourth Quarter 2023
7:26am
8-K
EX-1.1
5gq86
29 Dec 23
Entry into a Material Definitive Agreement
5:29pm
8-K
EX-10.1
b8tongdgd j18dwad
29 Dec 23
Entry into a Material Definitive Agreement
4:04pm
8-K
7ljwgg 61up
11 Oct 23
Departure of Directors or Certain Officers
4:06pm
8-K
EX-1.1
3mul m710a1y
2 Jun 23
Lexicon Announces Pricing of $125 Million Public Offering and Concurrent Private Placement
4:31pm
8-K
EX-10.1
n00o046bp0z dsr1f15
2 May 23
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-1.1
94vvm25fg g0uno
29 Jul 22
Lexicon Announces Proposed Public Offering of Common Stock
5:18pm
8-K
EX-3.1
4gpx9s
25 May 22
Material Modifications to Rights of Security Holders
8:27am